This Article  • Full text  • PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (1)  • Contact me when this article is cited  Related Content  • Related article  • Similar articles in this journal  Topic Collections  • Epilepsy  • Neurogenetics  • Genetics, Other  • Alert me on articles by topic  Social Bookmarking   What's this?

Stéphanie Baulac, PhD; Isabelle Gourfinkel-An, MD, PhD; Philippe Couarch, BS; Christel Depienne, PhD; Anna Kaminska, MD; Olivier Dulac, MD; Michel Baulac, MD; Eric LeGuern, MD, PhD; Rima Nabbout, MD, PhD

Arch Neurol. 2008;65(7):943-951.

Background  Generalized epilepsy with febrile seizures plus (GEFS⁺) is a familial autosomal dominant entity characterized by the association of febrile and afebrile seizures. Mutations in 3 genes—the sodium channel 1 subunit gene (SCN1A), the sodium channel β1 subunit gene (SCN1B), and the 2 GABA receptor subunit gene (GABRG2)—and linkage to 2 other loci on 2p24 and 21q22 have been identified in families with GEFS⁺, indicating genetic heterogeneity.

Objectives  To localize by means of linkage analysis a new gene for GEFS⁺ in a large family with 11 affected members and to test the new locus in 4 additional families with GEFS⁺.

Design  Family-based linkage analysis.

Setting  University hospital.

Patients  Five French families with GEFS⁺ and at least 7 available affected members with autosomal dominant transmission. All the patients had febrile seizures and/or afebrile generalized tonic-clonic seizures or absence epilepsy.

Main Outcome Measures  We analyzed 380 microsatellite markers and conducted linkage analysis.

Results  In the largest family, a 10-cM-density genomewide scan revealed linkage to a 13-Mb (megabase) interval on chromosome 8p23-p21 with a maximum pairwise logarithm of odds (LOD) score of 3.00 (at  = 0) for markers D8S351 and D8S550 and a multipoint LOD score of 3.23. A second family with GEFS⁺ was also possibly linked to chromosome 8p23-p21 and the region was narrowed to a 7.3-Mb candidate interval, flanked by markers D8S1706 and D8S549. We have not, so far, identified mutations in the coding exons of 6 candidate genes (MTMR9, MTMR7, CTSB, SGCZ, SG223, and ATP6V1B2) located in the genetic interval.

Conclusions  We report a sixth locus for GEFS⁺ on chromosome 8p23-p21. Because no ion channel genes are located in this interval, identification of the responsible gene will probably uncover a new mechanism of pathogenesis for GEFS⁺.

Author Affiliations: INSERM, UMR_S679 Neurologie and Thérapeutique Expérimentale (Drs S. Baulac, Gourfinkel-An, Depienne, and LeGuern and Mr Couarch), UPMC Univ Paris 06, UMR_S679 (Drs S. Baulac, Gourfinkel-An, Depienne, and LeGuern and Mr Couarch), Epileptology Unit, AP-HP, Groupe Hospitalier Pitié-Salpêtrière (Drs Gourfinkel-An and M. Baulac), Department of Paediatric Neurology, Hôpital Necker Enfants Malades, AP-HP (Drs Kaminska, Dulac, and Nabbout), INSERM, UMR_S663 and University Paris Descartes (Drs Kaminska, Dulac, and Nabbout), and AP-HP, Assistance Publique Hôpitaux de Paris, Groupe Hospitalier Pitié-Salpêtrière, Département de génétique et cytogénétique (Drs Depienne and LeGuern), Paris, France.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

RELATED ARTICLE

This Month in Archives of Neurology
Arch Neurol. 2008;65(7):871-872.
FULL TEXT  

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Novel susceptibility locus at chromosome 6q16.3-22.31 in a family with GEFS+
Poduri et al.
Neurology 2009;73:1264-1272.
ABSTRACT | FULL TEXT